BN Business News
Add your company to Business Communicator →

Zdrowie i gospodarka · 19/12/2014

Public Meeting on Patient-Focused Drug Development for Breast Cancer; Request for Comments

The Food and Drug Administration (FDA or Agency) is announcing a public meeting and an opportunity for public comment on patient- focused drug development for breast cancer. Patient-focused drug development is part of FDA's performance commitments made as part of the fifth authorization of the Prescription Drug User Fee Act (PDUFA V). The public meeting is intended to allow FDA to obtain patient perspectives on the impact of breast cancer on daily life and patient views on treatment approaches.

Source: Federal Register — Food and Drug AdministrationOpen original release →